Dance Biopharm's Unattributed VC - III Round

Dance Biopharm raised a round of funding on January 11, 2018. Investors include SternAegis Ventures.

Dance Biopharm is focused on the development of inhaled insulin products to treat diabetes patients worldwide.…

Articles about Dance Biopharm's Unattributed VC - III Round: